What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
Author(s) -
Jonathan I. D. Hamley,
David J. Blok,
Martin Walker,
Philip Milton,
Adrian Hopkins,
Louise Hamill,
Philip Downs,
Sake J. de Vlas,
Wilma A. Stolk,
Marı́a-Gloria Basáñez
Publication year - 2020
Publication title -
transactions of the royal society of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 105
eISSN - 1878-3503
pISSN - 0035-9203
DOI - 10.1093/trstmh/traa193
Subject(s) - onchocerciasis , onchocerca volvulus , ivermectin , mass drug administration , transmission (telecommunications) , pandemic , medicine , environmental health , epidemiology , covid-19 , demography , disease , veterinary medicine , immunology , population , engineering , telecommunications , sociology , infectious disease (medical specialty)
Mass drug administration (MDA) of ivermectin for onchocerciasis has been disrupted by the coronavirus disease 2019 (COVID-19) pandemic. Mathematical modelling can help predict how missed/delayed MDA will affect short-term epidemiological trends and elimination prospects by 2030.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom